Dermata Therapeutics Inc. Recorded Big Gain
Mon, Oct 24, 2022 at 07:35 PM
Dermata Therapeutics Inc. (DRMA:NASDAQ) shot up at $0.77, a gain of 18.1%. On Mon, Oct 24, 2022, DRMA:NASDAQ touched a New 2-Week High of $0.77. From Mon, Oct 10, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Aug 17, 2022 at $0.82 with a volume of 1M+.
About Dermata Therapeutics Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 62.43%
- Vaxcyte Inc. (PCVX:NASDAQ), 60.35%
- Mullen Automotive Inc. (MULN:NASDAQ), 32.94%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 24.76%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 23.13%
- NOVONIX Limited (NVX:NASDAQ), 22.1%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 20.6%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 18.1%
- uCloudlink Group Inc. (UCL:NASDAQ), 16.96%
- Elite Education Group International Ltd. (EEIQ:NASDAQ), 16.7%